Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PSF, CFG, MAT

Media Advisory - Minister Mendicino to make an announcement about preventing gun and gang violence in the City of Fredericton


OTTAWA, ON, Aug. 25, 2022 /CNW/ - Members of the media are invited to join the Honourable Marco Mendicino, Minister of Public Safety, to make an announcement regarding federal support for organizations on the front lines of the fight against gun and gang violence in the City of Fredericton, New Brunswick.

He will be joined by Jenica Atwin, Member of Parliament for Fredericton and Her Worship Kate Rogers, Mayor of Fredericton.

Following the announcement, Minister Mendicino will take questions from the media.

This event will also be livestreamed via Public Safety Canada's Twitter channels: @Safety_Canada and @Securite_Canada.

Date
Friday, August 26, 2022

Time
9:45 a.m. ADT

Location 
Fredericton Public Library 
12 Carleton Street 
Fredericton, New Brunswick

Media representatives who wish to attend the event must arrive at least 15 minutes in advance to sign in and present photo ID and credentials.

Media and guests are asked to respect local physical distancing guidelines. Participants will be required to share their name and phone number for possible contact tracing. Wearing masks is required, especially when not able to maintain physical distance.

Public health protocols are in effect: please stay home if you are experiencing any of the symptoms listed here: About Coronavirus (COVID-19) | Public Health New Brunswick, practice good hand washing and other hygiene steps, as well as physical distancing.

SOURCE Public Safety and Emergency Preparedness Canada


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: